The biopharmaceutical industry in China: history and future perspectives Kai GaoJunzhi Wang Review 28 April 2012 Pages: 101 - 111
Identification of cancer stem cells provides novel tumor models for drug discovery Douglas D. FangDanyi WenYajun Xu Review 09 May 2012 Pages: 112 - 121
Translational medicine in hepatocellular carcinoma Qiang GaoYinghong ShiJia Fan Review 09 May 2012 Pages: 122 - 133
MicroRNAs and lung cancers: from pathogenesis to clinical implications Ji QiDavid Mu Review 18 April 2012 Pages: 134 - 155
The role of PARP1 in the DNA damage response and its application in tumor therapy Zhifeng WangFengli WangCaixia Guo Review 03 June 2012 Pages: 156 - 164
Particle therapy for cancers: a new weapon in radiation therapy Guo-Liang Jiang Review 09 May 2012 Pages: 165 - 172
Nucleic acid-based diagnostics for infectious diseases in public health affairs Albert Cheung-Hoi YuGreg VatcherLok-Ting Lau Review 03 June 2012 Pages: 173 - 186
Current progress on natural orifice transluminal endoscopic surgery (NOTES) Junqing WangLu ZhangWeize Wu Review 08 May 2012 Pages: 187 - 194
Improved dissolution and anti-inflammatory effect of ibuprofen by solid dispersion Liyuan ChenQifeng DangXiguang Chen Research Article 09 May 2012 Pages: 195 - 203
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era Haiyan HeYang ShenSaijuan Chen Research Article 03 June 2012 Pages: 204 - 211
A comprehensive information database (CID) of breast cancer patients in China Shuai LiLi Fu Letter to Frontiers of Medicine 08 May 2012 Pages: 212 - 216
Prevalence and causes of air pollution and lung cancer in Xuanwei City and Fuyuan County, Yunnan Province, China Yi CaoHuaping Gao Letter to Frontiers of Medicine 09 May 2012 Pages: 217 - 220
Social insurance for occupational diseases Hengjin DongShengnan DuanXujun Ye Health Policy Forum 18 April 2012 Pages: 221 - 223